Pramodini Medicare IPO is a book build issue of 58,51,200 shares (₹69.04 Cr.). The issue is a combination of a fresh issue of 53,50,800 shares (₹63.14 Cr.) and an offer for sale of 5,00,400 shares (₹5.90 Cr.).
The Pramodini Medicare IPO will open on August 12, 2026, and close on August 14, 2026. The price band for the IPO is fixed at ₹110 to ₹118 per share. The minimum application size is 2 lot (2,400 shares), requiring a retail investor to invest at least ₹2,83,200 (based on the upper price band).
Pramodini Medicare IPO Details
| Open Date | August 12, 2026 |
| Close Date | August 14, 2026 |
| Issue Type | Book Building Issue |
| Face Value | ₹10.00 Equity Share |
| Price Band | ₹110.00 – ₹118.00 Per Share |
| Listing On | NSE, SME |
| Issue Size | ₹69.04 Cr. (58,51,200 Shares) |
| Fresh Issue | ₹63.14 Cr. (53,50,800 Shares) |
| Offer For Sale | ₹5.90 Cr. (5,00,400 Shares) |
| Prospectus | RHP | Anchor Investors |
Pramodini Medicare IPO Reservation
A total of 58,51,200 shares are on offer in the Pramodini Medicare IPO, of which 29,25,600 shares have been allotted to QIBs, 8,77,680 shares to NIIs, and 20,47,920 shares to RIIs.
| Category | Reservation | Shares Offered |
|---|---|---|
| QIB | 50.00% | 29,25,600 |
| NII | 15.00% | 8,77,680 |
| RII | 35.00% | 20,47,920 |
| Total | 100.00% | 58,51,200 |
Pramodini Medicare IPO Market Lot
Retail investors can apply for the Pramodini Medicare IPO minimum & maximum 2 lot of 2,400 shares for an application amount of ₹2,83,200.
| Application | Lot | Shares | Amount |
| Retail Minimum & Maximum | 2 | 2,400 | ₹2,83,200 |
| S-HNI Minimum | 3 | 3,600 | ₹4,24,800 |
| S-HNI Maximum | 7 | 8,400 | ₹9,91,200 |
| B- HNI Minimum | 8 | 9,600 | ₹11,32,800 |
Key Performance Indicator
| KPI [March 31, 2026] | Value |
| Market Capitalisation | ₹260.14 Cr. |
| P/E Ratio | 11.34x |
| EPS | ₹10.41 |
| ROE | 39.08% |
| ROCE | 34.66% |
| RoNW | 32.69% |
| Dept/Equity | 0.34 |
| EBITDA Margin | 49.61% |
| PAT Margin | 27.90% |
| Net Assets Value | ₹31.84 |
| Price To Book Value | ₹3.71 |
Pramodini Medicare IPO Peer Comparison
| Company | P/E | EPS | RoNW | NAV |
| Invicta Diagnostic Limited | 13.62x | ₹4.90 | 9.76% | ₹39.71 |
| Krsnaa Diagnostics Limited | 16.74x | ₹31.30 | 10.35% | ₹302.23 |
| Star Imaging & Path Labs Limited | 7.87x | ₹11.05 | 16.58% | ₹66.65 |
Pramodini Medicare IPO Dates
Pramodini Medicare IPO open for subscription August 12, 2026, and close date on August 14, 2026. The allotment will be finalized on August 17, 2026, and the IPO listing on August 19, 2026.
| Open Date | August 12, 2026 |
| Close Date | August 14, 2026 |
| Allotment Date | August 17, 2026 |
| Refund Date | August 18, 2026 |
| Share Credit Date | August 18, 2026 |
| Listing Date | August 19, 2026 |
Pramodini Medicare Limited Company Financial Report
| Period Ended | Total Assets | Total Income | Total Expenses | Net Worth | Profit After Tax | EBITDA | Reserves and Surplus | Total Borrow |
|---|---|---|---|---|---|---|---|---|
| March 2026 | ₹93.62 Cr. | ₹63.38 Cr. | ₹40.08 Cr. | ₹53.15 Cr. | ₹17.38 Cr. | ₹30.90 Cr. | ₹36.46 Cr. | ₹17.85 Cr. |
| March 2025 | ₹56.45 Cr. | ₹38.55 Cr. | ₹22.80 Cr. | ₹35.77 Cr. | ₹11.14 Cr. | ₹20.97 Cr. | ₹34.49 Cr. | ₹10.81 Cr. |
| March 2024 | ₹48.78 Cr. | ₹35.79 Cr. | ₹25.72 Cr. | ₹24.75 Cr. | ₹7.14 Cr. | ₹15.53 Cr. | ₹23.46 Cr. | ₹11.96 Cr. |
Company Promoters
- Chalasani Durga Aashritha
- Chalasani Kavitha
- Chalasani Kuldeep Kumar
- Chalasani Lalithakumar
- Sri Ram Medicare Private Limited
| Holding Pre Issue | 85.71% |
| Holding Post Issue | 62.64% |
Pramodini Medicare IPO Lead Managers
- Smart Horizon Capital Advisors Private Limited
Pramodini Medicare IPO Registrar
Purva Sharegistry (India) Private Limited
Phone: +91-022-23018261/ 23016761
Email: newissue@purvashare.com
Website: https://www.purvashare.com/investor-service/ipo-query
About Pramodini Medicare Limited
Incorporated in 2000, Pramodini Medicare Limited is a technology-enabled diagnostic service provider operating across India. The company offers complete diagnostic capabilities in the radiology, clinical laboratory, and nuclear medicine segments, serving public and private hospitals, public sector companies, medical colleges, and private diagnostic centers in Tier I, II, and III cities. Its extensive medical imaging and testing portfolio includes advanced radiology services—such as MRI, CT scan, digital X-ray, ultrasound with color Doppler, mammography, DEXA scan, and interventional radiology—as well as core clinical laboratory departments, including hematology, microbiology, immunology, pathology, and biochemistry. Additionally, the company offers specialized nuclear medicine procedures, including PET-CT, SPECT, and nuclear therapy, supported by a 24×7 centralized teleradiology hub and processing laboratory in Vijayawada.
The company operates its diagnostic infrastructure through a multi-pronged service delivery structure designed to meet diverse healthcare demands. Its main operational routes include public-private partnerships (PPPs) with government hospitals and medical colleges, private-private partnerships (Private-Private Partnerships) with private healthcare institutions, strategic joint initiatives with central PSUs in several states, and company-owned standalone diagnostic centers that directly serve retail patients. Within these frameworks, individual diagnostic centers operate through long-term agreements and MOUs customized to each location’s operational scope, allowing for flexible expansion and localized service delivery.
Through this balanced operational mix, the company has established a strong presence across hospitals, institutional clients, and walk-in patients. As of August 4, 2026, the company manages a network of 16 diagnostic centers across seven states. The firm’s expansion is further supported by a robust IT infrastructure, strong technical capabilities, consistent financial performance, and an experienced management team with deep domain expertise. The company has retained a core staff of 161 permanent employees until March 31, 2026, to maintain its nationwide diagnostic network, teleradiology operations, laboratory processing, and administrative functions.
Objects Of The Issue
- Funding of capital expenditure for purchase of Medical Equipments towards Existing and Proposed Diagnostic Centres. (Estimated Ammount ₹45.15 Cr.)
- General corporate purposes and unidentified inorganic acquisition
Company Address
Pramodini Medicare Limited
D. No: – 29-4-54K, CSI Complex,
Prakasam Road,
Suryaraopet
Vijayawada, Andhra Pradesh, 520002
Phone: +91 9985782727
Email: investors@pramodinidiagnostics.com
Website: https://www.pramodinidiagnostics.com/
Pramodini Medicare IPO FAQs
What is Pramodini Medicare IPO?
Pramodini Medicare IPO is a SME IPO of 58,51,200 equity shares of the face value of ₹10 aggregating up to ₹69.04 Crores. The IPO issue priced at ₹110 to ₹118 per share.
What are the open and close dates of the Pramodini Medicare IPO?
The IPO will open on August 12, 2026 and will close on August 14, 2026.
What is the price band for Pramodini Medicare IPO?
The price band for the IPO is fixed at ₹110 to ₹118 per share.
What is the issue size of the Pramodini Medicare IPO?
The total issue size of the IPO is ₹69.04 Cr., comprising both fresh issue and offer for sale (if applicable).
What is Pramodini Medicare IPO Minimum and Maximum Lot Size?
The minimum & maximum bid is 2 Lot, 2,400 Shares with ₹2,83,400 amount for the IPO.
What is Pramodini Medicare IPO Investors Portion?
The investors’ portion for QIB 50%, NII 15%, RII 35% for the IPO.
When will the basis of allotment for the Pramodini Medicare IPO be finalized?
The the IPO allotment is expected to be finalized on August 17, 2026.
When will the shares of Pramodini Medicare IPO get listed?
The IPO shares are expected to be listed on the NSE and SME on August 19, 2026.
This content has been researched and written by the IPO Investors Team…
Disclaimer: Readers are strongly advised to seek guidance from a qualified financial advisor before making any investment decisions. Relying solely on the content presented here for financial choices is done entirely at the reader’s own risk.
| Thank You… |
|---|